Biomarkers in management of inflammatory bowel disease

In recent years the use of faecal and serologic biomarkers has been evaluated in the diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) has been proposed as a surrogate marker for intestinal inflammation; elevated concentrations in IBD patients have been confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Moniuszko, Andrzej, Wiśniewska, Anna, Rydzewska, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Review Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027818/
https://www.ncbi.nlm.nih.gov/pubmed/24868269
http://dx.doi.org/10.5114/pg.2013.38728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027818/
https://www.ncbi.nlm.nih.gov/pubmed/24868269
http://dx.doi.org/10.5114/pg.2013.38728

Ejemplares similares